Key result
Catheter ablation reduces mortality and improves LVEF versus medical therapy in AF with LVEF 36-50%.
Why the study?
Reported benefits of catheter ablation versus medical treatment in patients with AF and HF have been inconsistent across RCTs due to differing enrollment criteria, prompting stratification by LVEF and AF type.
Does catheter ablation improve clinical and functional outcomes compared to medical treatment in patients with atrial fibrillation and heart failure?
Meta-Analysis
Does catheter ablation improve clinical and functional outcomes compared to medical treatment in patients with atrial fibrillation and heart failure?
Catheter ablation provides significant clinical and functional benefits over medical therapy in patients with AF and HF, particularly those with mildly reduced LVEF (36-50%) and mixed AF types.
Answers are grounded in this paper and cite their sources.
Supports ablation over medical therapy in AF with LVEF 36-50%; extends RCT evidence to HFmrEF.
Background: The benefit of catheter ablation vs. medical treatment has been reported to be inconsistent in randomized controlled trials (RCTs) for patients with atrial fibrillation (AF) and heart failure (HF) due to different enrollment criteria. This meta-analysis aimed to decipher the differential outcomes stratified by different left ventricular ejection fractions (LVEFs) and AF types. Methods: We searched PubMed, Embase, ProQuest, ScienceDirect, Cochrane Library, ClinicalKey, Web of Science, and ClinicalTrials.gov databases for RCTs comparing medical treatment and catheter ablation in patients with AF and HF published before March 31, 2023. Nine studies were included. Results: When patients were stratified by LVEF, improved LVEF and 6-min walk distance, less AF recurrence, and lower all-cause mortality in favor of catheter ablation were observed in patients with LVEF ≤50% but not in patients with LVEF ≤35%, and short HF hospitalization was observed in patients with LVEF ≤50% and LVEF ≤35%. When patients were stratified by AF types, improved LVEF and 6-min walk distance, better HF questionnaire score, and short HF hospitalization in favor of catheter ablation were observed both in patients with nonparoxysmal AF and mixed AF (paroxysmal and persistent) and less AF recurrence and lower all-cause mortality in favor of catheter ablation were observed in only patients with mixed AF. Conclusions: This meta-analysis showed improved LVEF and 6-min walk distance, less AF recurrence, and lower all-cause mortality in favor of catheter ablation vs. medical treatment in AF patients with HF and LVEF of 36%-50%. Compared with medical treatment, catheter ablation improved LVEF and had better HF status in patients with nonparoxysmal AF and mixed AF; however, AF recurrence and all-cause mortality in favor of catheter ablation were observed in only HF patients with mixed AF.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2023) conducted a meta-analysis in Atrial fibrillation and heart failure. Catheter ablation vs. Medical treatment was evaluated. In a meta-analysis of 9 RCTs, catheter ablation improved LVEF, 6-min walk distance, AF recurrence, and all-cause mortality vs medical treatment in AF patients with heart failure and LVEF 36%-50%.
Synapse has enriched 10 related papers. Consider them for comparative context: